Lianghua Bin1, Michael G Edwards2, Ryan Heiser1, Joanne E Streib1, Brittany Richers1, Clifton F Hall1, Donald Y M Leung3. 1. Department of Pediatrics, National Jewish Health, Denver, Colo. 2. Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Denver, Aurora, Colo. 3. Department of Pediatrics, National Jewish Health, Denver, Colo; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colo. Electronic address: leungd@njhealth.org.
Abstract
BACKGROUND: A subset of patients with atopic dermatitis (AD) is prone to disseminated herpes simplex virus (HSV) infection (ie, atopic dermatitis with a history of eczema herpeticum [ADEH+]). Biomarkers that identify ADEH+ are lacking. OBJECTIVE: We sought to search for novel ADEH+ gene signatures in PBMCs. METHODS: An RNA-sequencing approach was applied to evaluate global transcriptional changes by using PBMCs from patients with ADEH+ and patients with atopic dermatitis without a history of eczema herpeticum (ADEH-). Candidate genes were confirmed by means of quantitative PCR or ELISA. RESULTS: PBMCs from patients with ADEH+ had distinct changes to the transcriptome when compared with those from patients with ADEH- after HSV-1 stimulation: 792 genes were differentially expressed at a false discovery rate of less than 0.05 (ANOVA), and 15 type I and type III interferon genes were among the top 20 most downregulated genes in patients with ADEH+. We further validated that IFN-α and IL-29 mRNA and protein levels were significantly decreased in HSV-1-stimulated PBMCs from patients with ADEH+ compared with those from patients with ADEH- and healthy subjects. Ingenuity Pathway Analysis demonstrated that the upstream regulators of type I and type III interferons, interferon regulatory factor (IRF) 3 and IRF7, were significantly inhibited in patients with ADEH+ based on the downregulation of their target genes. Furthermore, we found that gene expression of IRF3 and IRF7 was significantly decreased in HSV-1-stimulated PBMCs from patients with ADEH+. CONCLUSIONS: PBMCs from patients with ADEH+ have a distinct immune response after HSV-1 exposure compared with those from patients with ADEH-. Inhibition of the IRF3 and IRF7 innate immune pathways in patients with ADEH+ might be an important mechanism for increased susceptibility to disseminated viral infection.
BACKGROUND: A subset of patients with atopic dermatitis (AD) is prone to disseminated herpes simplex virus (HSV) infection (ie, atopic dermatitis with a history of eczema herpeticum [ADEH+]). Biomarkers that identify ADEH+ are lacking. OBJECTIVE: We sought to search for novel ADEH+ gene signatures in PBMCs. METHODS: An RNA-sequencing approach was applied to evaluate global transcriptional changes by using PBMCs from patients with ADEH+ and patients with atopic dermatitis without a history of eczema herpeticum (ADEH-). Candidate genes were confirmed by means of quantitative PCR or ELISA. RESULTS: PBMCs from patients with ADEH+ had distinct changes to the transcriptome when compared with those from patients with ADEH- after HSV-1 stimulation: 792 genes were differentially expressed at a false discovery rate of less than 0.05 (ANOVA), and 15 type I and type III interferon genes were among the top 20 most downregulated genes in patients with ADEH+. We further validated that IFN-α and IL-29 mRNA and protein levels were significantly decreased in HSV-1-stimulated PBMCs from patients with ADEH+ compared with those from patients with ADEH- and healthy subjects. Ingenuity Pathway Analysis demonstrated that the upstream regulators of type I and type III interferons, interferon regulatory factor (IRF) 3 and IRF7, were significantly inhibited in patients with ADEH+ based on the downregulation of their target genes. Furthermore, we found that gene expression of IRF3 and IRF7 was significantly decreased in HSV-1-stimulated PBMCs from patients with ADEH+. CONCLUSIONS: PBMCs from patients with ADEH+ have a distinct immune response after HSV-1 exposure compared with those from patients with ADEH-. Inhibition of the IRF3 and IRF7 innate immune pathways in patients with ADEH+ might be an important mechanism for increased susceptibility to disseminated viral infection.
Authors: Sabine Vollstedt; Susi Arnold; Cornelia Schwerdel; Marco Franchini; Gottfried Alber; James P Di Santo; Mathias Ackermann; Mark Suter Journal: J Virol Date: 2004-04 Impact factor: 5.103
Authors: Cihan Papan; Beate Hagl; Valerie Heinz; Michael H Albert; Oliver Ehrt; Julie Sawalle-Belohradsky; Jens Neumann; Martin Ries; Philip Bufler; Andreas Wollenberg; Ellen D Renner Journal: J Allergy Clin Immunol Date: 2014-04-01 Impact factor: 10.793
Authors: Yvonne J Huang; Benjamin J Marsland; Supinda Bunyavanich; Liam O'Mahony; Donald Y M Leung; Antonella Muraro; Thomas A Fleisher Journal: J Allergy Clin Immunol Date: 2017-02-28 Impact factor: 10.793
Authors: Stephan Traidl; Petra Kienlin; Gabriele Begemann; Lichen Jing; David M Koelle; Thomas Werfel; Lennart M Roesner Journal: J Allergy Clin Immunol Date: 2017-11-16 Impact factor: 10.793
Authors: Lianghua Bin; Claire Malley; Patricia Taylor; Meher Preethi Boorgula; Sameer Chavan; Michelle Daya; Malaika Mathias; Gautam Shankar; Nicholas Rafaels; Candelaria Vergara; Joseph Potee; Monica Campbell; Jon M Hanifin; Eric Simpson; Lynda C Schneider; Richard L Gallo; Tissa Hata; Amy S Paller; Anna De Benedetto; Lisa A Beck; Peck Y Ong; Emma Guttman-Yassky; Brittany Richers; David Baraghoshi; Ingo Ruczinski; Kathleen C Barnes; Donald Y M Leung; Rasika A Mathias Journal: Allergy Date: 2021-03-15 Impact factor: 13.146
Authors: Lianghua Bin; Xiaozhao Li; Brittany Richers; Joanne E Streib; Jack W Hu; Patricia Taylor; Donald Y M Leung Journal: J Allergy Clin Immunol Date: 2018-01-31 Impact factor: 10.793
Authors: Lianghua Bin; Kathleen C Barnes; Li Gao; Nicholas M Rafaels; Lili Huang; Joseph Potee; Ingo Ruczinski; Terri H Beaty; Amy S Paller; Lynda C Schneider; Rich Gallo; Jon M Hanifin; Lisa A Beck; Raif S Geha; Rasika A Mathias; Donald Y M Leung Journal: J Allergy Clin Immunol Date: 2015-09-03 Impact factor: 10.793